Carsyon 2 Te Egyan Nov18

30 Questions | Total Attempts: 180

SettingsSettingsSettings
Please wait...
Carsyon 2 Te Egyan Nov18

. Welcome to TE E-GYAN Test Here is an opportunity to test your Product knowledge. You have 20 minutes to complete this test. Please enter your Name , Emp. Code ,HQ and Select your state. Then press "Start" to begin the test. You can only attend the test once and hence make sure you have uninterrupted internet connectivity. All the best Micro Leadership Academy


Questions and Answers
  • 1. 
    The competitor brand of Rosuvastatin and Clopidogrel from Ajanta pharma is
    • A. 

      Rosufit CV

    • B. 

      Rosumac CV

    • C. 

      Novastat CV

    • D. 

      Zyrova CV

  • 2. 
    US Task Force 2016 recommends
    • A. 

      Statins should be given to all Diabetics

    • B. 

      High Dose statin should be given to high risk individuals

    • C. 

      Low to moderate dose statin should be given to adults 40 -75 years old who do not have a history of CVD but have atleast one CV risk factor

    • D. 

      Combination treatment to treat Lipid Triad

  • 3. 
    Most of the high risk dyslipidemic Indian patients are on
    • A. 

      Optimal dosage of statin

    • B. 

      Sub optimal dosage of statin

    • C. 

      High dose of statin

    • D. 

      Combination of Statin combinations

  • 4. 
    Turbovas F is often needed to treat Lipid Triad we mean
    • A. 

      Low HDL, High TG, High LDL

    • B. 

      High HDL, Low LDL, High TG

    • C. 

      Low HDL, Low LDL, High TG

    • D. 

      High HDL, High LDL, High TG

  • 5. 
    Rosuvastatin acts by
    • A. 

      It  is an antiplatelet agent & prevents clot formation

    • B. 

      activates PPAR alpha & lowers Triglycerides in the blood.

    • C. 

       inhibits the enzyme HMGCoA Reductase and prevents the formation of cholesterol.

    • D. 

      All of the Above

  • 6. 
    Turbovas F USP
    • A. 

       Improves Lipid Tiad  (High LDL, High TG, Low HDL) 2. ADA recommends combination to be considered in patients with TG> 204 mg/dl & HDL <34 mg/dl

    • B. 

      prevents future events

    • C. 

      (non CYP3A4 metabolized statin)  enhances the efficacy of Clopidogrel unlike Atorvastatin (CYP3A4 metabolized statin). 2. Together, lT prevents future events

    • D. 

      Both 2 & 3

  • 7. 
    Price of Turbovas ASP 
    • A. 

      Rs.20

    • B. 

      Rs.29

    • C. 

      Rs.48

    • D. 

      Rs.48.5

  • 8. 
    Price of Turbovas is
    • A. 

      Rs. 25/tablet

    • B. 

      Rs. 30/tablet

    • C. 

      Rs. 20/tablet

    • D. 

      Rs. 27/ Tablet

  • 9. 
    Indication for Turbovas CV
    • A. 

      In Dyslipidemia

    • B. 

      In Mixed dyslipidemia 

    • C. 

      IN 1 & 2

    • D. 

      In Secondary prevention of ACS & Ischemic Stroke

  • 10. 
    The main benefit  of HPMC Technology used in Dianorm OD 
    • A. 

      Makes Dianorm OD more Safe

    • B. 

      Makes tablet size of Dianorm OD small

    • C. 

      Offers similar release profile of full and half tablet

    • D. 

      All of the Above

  • 11. 
    Azilsartan contains which moiety (Ring)?
    • A. 

      Triazole

    • B. 

      Tetrazole

    • C. 

      Oxo- Oxadiazole

    • D. 

      Imidazole

  • 12. 
    Azilsartan offers additional Vasodilation due to?
    • A. 

      Action on ACE-2/ Ang (1-7) and mass receptor

    • B. 

      Action on AT1 receptor

    • C. 

      By blocking AT2 receptor

    • D. 

      By PPAR- Gamma activity

  • 13. 
    Azilsartan has got ____IC50 value than Olmesartan?
    • A. 

      Higher

    • B. 

      Lower

    • C. 

      Similar

    • D. 

      None of the above

  • 14. 
    Which is one of the most effective 2 drug combination to treat Hypertension according to Hurst's The Heart textbook?
    • A. 

      ARB & Betablockers

    • B. 

      ARB & Calcium Channel Blockers

    • C. 

      ARB & Diuretics

    • D. 

      ARB & ACEI

  • 15. 
    Azilsartan is ____% more effective than Olmesartan for BP control
    • A. 

      31%

    • B. 

      50%

    • C. 

      35%

    • D. 

      51%

  • 16. 
    Is dose adjustment of Azilsartan is required in Renal impairment patients?
    • A. 

      Yes

    • B. 

      No

    • C. 

      Sometimes

    • D. 

      None of the Above

  • 17. 
    Chlorthalidone belongs to which class of diuretics??
    • A. 

      Thiazide

    • B. 

      Potasium Sparing diuretics

    • C. 

      Loop Diuretics

    • D. 

      Thiazide like diuretics

  • 18. 
    The second prevalence study will focus on
    • A. 

      ZILARTA

    • B. 

      ZILARTA & ZILARTA CT both

    • C. 

      ZILARTA CT

    • D. 

      None of the above

  • 19. 
    ____________% of patients achieved BP control with Azilsartan and Chlorthalidone Fixed Dose combination
    • A. 

      81%

    • B. 

      76%

    • C. 

      90%

    • D. 

      70%

  • 20. 
    Gliclazide is basically
    • A. 

      SU

    • B. 

      BIGUANIDES

    • C. 

      PPAR GAMMA ACTIVATOR

    • D. 

      GLIPTIN

  • 21. 
    What is the full form of RCPA?
    • A. 

      Retail Chemist Product Availablity

    • B. 

      Retail Chemist Prescription Audit

    • C. 

      Retail Counter product Audit                

    • D. 

      None of above

  • 22. 
    RCPA should start with
    • A. 

      POB

    • B. 

      Servicing

    • C. 

      Taking information

    • D. 

      Rapport building

  • 23. 
    During RCPA need to ask about
    • A. 

      Quantified information of our Brand

    • B. 

      Quantified information of Competitor Brand

    • C. 

      Pack & Price of Competitor Brand

    • D. 

      All of above

  • 24. 
    RCPA is helpful to
    • A. 

      Select a right customer for Right Brand

    • B. 

      Know the habit of Presciption of Dr

    • C. 

      Plan a Strategy

    • D. 

      All of above

  • 25. 
    If a brand is lying at chemist and not moving then we should 
    • A. 

      Ignore it

    • B. 

      Try to liquidate it

    • C. 

      ask the chemist to return

    • D. 

      None of above

Back to Top Back to top